A few have small trials, and none is proven. The peptides sold for hair are cosmetic ingredients in serums and shampoos. The studies behind them are small and short. Every one found tests a blend of ingredients, not the peptide on its own.
That matters because you have tested options. This page sets the peptides beside them. It sits alongside the other peptides for skin pages, since the same ingredients show up in both.
What works for pattern hair loss
Start with the baseline. For androgenetic alopecia, or pattern hair loss, a 2025 review names three effective therapies [1]. They are hair transplant, oral finasteride and topical minoxidil.
Not everyone responds to them, and daily use is hard to keep up. That gap is why new options are studied. The same review lists hair-follicle-activating peptides as an emerging approach, not an established one.
The best peptide trial: a blend against minoxidil
One trial compared a peptide blend with minoxidil directly [2]. It randomized 32 adults with mild to moderate pattern hair loss (n = 32). Half were men.
One group applied a blend of acetyl tetrapeptide-3, biochanin A and ginseng. The other applied 3% minoxidil. Both used 1 mL twice a day for 24 weeks.
Terminal hair counts rose 8.3% on the blend and 8.7% on minoxidil. The difference was not significant. One person on minoxidil developed scalp eczema.
Read it for what it is. It is small and short. Its comparison was 3% minoxidil. It could not show which ingredient in the blend did the work.
Copper peptide on the scalp
A copper tripeptide serum was tested in 2024 [3]. It was paired with an exfoliating scalp scrub and several other actives. The study was open-label, lasted 15 days, and enrolled adults with dandruff.
Flaking fell 61.24% by day 15 (p < 0.0001). A scalp camera also read hair density up 12.48%. With no control group and a two-week run, that is not a hair-growth result.
Copper peptide’s wider record, and why its route matters, is in GHK-Cu, topical versus injected.
If you are on a GLP-1 peptide
Some readers searching this are on a GLP-1 drug, which is also a peptide. A 2026 meta-analysis of 9 interventional studies looked at hair loss on these drugs [5]. It included 4,114 people taking them.
Hair loss was more likely than on placebo, with a risk ratio of 3.25 (95% CI 1.44 to 7.36). About 3.9% of users reported it. If this is your situation, raise it with your prescriber. Weight-loss goals and their drugs are covered under the weight goal.
How to use this
If you want the option with the most evidence, ask a doctor about minoxidil or finasteride. If you try a peptide serum, treat it as an add-on with little data behind it. The same caution applies to injected peptides like BPC-157, which has no hair trials at all.